Displaying 1 - 3 of 3
| Active Ingredient | BROMOCRIPTINE |
| Therapeutic Class | DOPAMINE RECEPTOR AGONIST |
| Indications |
Hyperprolactinemia (Amenorrhoea, female infertility ); parkinsonism; suppression of lactation. |
| Caution | Nausea, hypotension, headache, peripheral vasocontriction. The use of Bromocrip tine for the sup p ression of post -partum lactation has been withdrawn by the FDA due to severe side effects report More ... |
| Dose Range |
Amenorrhea second to hyperprolactinemia: 2.5mg-5mg 2 times daily .Parkinsonism: 1.25-2.5mg twice daily .Take with food or milk. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CABERGOLINE |
| Therapeutic Class | DOPAMINE RECEPTOR AGONIST |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIAGNOSTIC BLOOD GLUCOSE |
| Therapeutic Class | DIABETES MELLITUS |
| Indications |
Blood glucose monitoring. The BDS will reimburse for one bottle of 50’s testing strip s every 3 months to patients on oral diabetic medication or those diabetic patients controlled on diet an More ... |
| Caution |
Patients should be properly trained in the use of blood glucose monitoring sy stems. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |